US Women's Health Diagnostics Market
US Women's Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-Users (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period, (2026-2035)
Industry Overview
US women's health diagnostics market was valued at $7,506.9 million in 2025 and is projected to reach $15,656.4 million by 2035, growing at a CAGR of 7.7% during the forecast period (2026–2035). The US Women’s Health Diagnostics Market is evolving as healthcare providers and diagnostic laboratories increasingly prioritize early detection, personalized screening, and precision-driven care for women. Market growth is being driven by the widespread adoption of advanced imaging technologies, molecular diagnostics, and biomarker-based tests that enhance diagnostic accuracy for conditions such as breast, cervical, and ovarian cancers. Demand is further fueled by rising awareness of preventive healthcare, expanding national screening programs, and the increasing prevalence of lifestyle- and age-related disorders among women. As healthcare regulations emphasize standardized and evidence-based diagnostic protocols, women’s health diagnostics solutions are becoming essential in improving early detection rates, enabling timely intervention, and optimizing clinical outcomes.
Market Dynamics
Rising Focus on Early Detection and Preventive Screening
Healthcare providers and diagnostic organizations in the U.S. are increasingly prioritizing early detection and preventive care for women-specific conditions, including breast cancer, cervical cancer, reproductive health disorders, and other chronic diseases. The growing emphasis on personalized healthcare is driving adoption of advanced diagnostic technologies such as molecular assays, imaging systems, and point-of-care testing solutions. Providers are seeking tools that improve diagnostic accuracy, reduce turnaround times, and support evidence-based clinical decisions. As patient awareness and screening initiatives expand, demand for comprehensive and reliable women’s health diagnostics solutions continues to strengthen, shaping the trajectory of market growth.
Advancements in AI, Digital Health, and Automation
The integration of AI-driven algorithms, automated analytics, and digital health platforms is transforming women’s health diagnostics in the U.S. AI-enabled imaging interpretation, predictive modeling, and cloud-based data management are allowing clinicians to process larger patient datasets with enhanced precision and speed. Diagnostic technology providers are investing in scalable, interoperable platforms that streamline workflows across laboratories, hospitals, and home-care settings. These innovations help reduce diagnostic errors, optimize clinical efficiency, and enable more personalized treatment planning. Consequently, the growing adoption of intelligent, automated, and digitally integrated diagnostics solutions is emerging as a major driver of market expansion.
Market Segmentation
- Based on the application, the market is segmented into breast cancer testing, cervical cancer testing, pregnancy & fertility testing, ovarian cancer testing, infectious disease testing, ultrasound tests, sexually transmitted disease testing, and others.
- Based on the end-user, the market is segmented into diagnostic and imaging centers, hospitals and clinics, and home care.
Breast Cancer Testing Segment to Lead the Market with the Largest Share
In the US, breast cancer testing is the leading segment in the women’s health diagnostics market, supported by high disease prevalence and comprehensive national screening programs. Advanced imaging technologies, molecular diagnostics, and biomarker-based tests are widely adopted to improve accuracy and facilitate early intervention. Innovations in mammography, ultrasound, and companion diagnostics continue to reduce false positives while improving detection rates, maintaining the segment’s market dominance.
Hospitals and Clinics: A Key End-User Segment Driving Market Growth
Hospitals and clinics remain the primary end users in the US, with access to advanced diagnostic infrastructure, skilled personnel, and integrated care pathways. Rising patient demand for routine screenings, prenatal testing, and oncology diagnostics drives adoption, while ongoing investments in laboratory automation and imaging systems enhance throughput and operational efficiency.
Market Players Outlook
The major companies operating in the US women's health diagnostics market include Abbott Laboratories, F. Hoffmann?La Roche Ltd (Roche Diagnostics), Hologic, Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In March 2025, Hologic Inc. expanded its breast and cervical cancer screening portfolio with AI-assisted mammography and HPV molecular testing solutions, supporting large-scale screening initiatives in public and private hospitals.
- In January 2025, Abbott Laboratories launched new point-of-care ultrasound systems for obstetrics and gynecology, aimed at enhancing diagnostic precision and workflow efficiency in hospital networks and diagnostic centers.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the US women's health diagnostics
- Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- US Women’s Health Diagnostics Market Sales Analysis – Application | End-Users ($ Million)
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Women’s Health Diagnostics Industry Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For US Women’s Health Diagnostics Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For US Women’s Health Diagnostics Market: Impact Analysis
- Market Opportunities
- Opportunities For US Women’s Health Diagnostics Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – US Women’s Health Diagnostics Market Revenue and Share by Manufacturers
- Women’s Health Diagnostics Product Comparison Analysis
- Key Company Analysis
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hoffmann-La Roche Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hologic, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Labcorp Holdings Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Quest Diagnostics Incorporated
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Abbott Laboratories
- Key Company Analysis
- US Women’s Health Diagnostics Market Sales Analysis by Application ($ Million)
- Breast Cancer Testing
- Cervical Cancer Testing
- Pregnancy & Fertility Testing
- Ovarian Cancer Testing
- Infectious Disease Testing
- Ultrasound Tests
- Sexually Transmitted Disease Testing
- Others
- US Women’s Health Diagnostics Market Sales Analysis by End-Users ($ Million)
- Diagnostic and Imaging Centers
- Hospitals and Clinics
- Home Care
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Aspira Women’s Health Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company (BD)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- bioMérieux SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio?Rad Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cardinal Health, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Carestream Health, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cepheid (Danaher subsidiary)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- DiaSorin S.p.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann?La Roche Ltd (Roche Diagnostics)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE HealthCare Technologies Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hologic, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V. (Philips Healthcare)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Labcorp Holdings Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Myriad Genetics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Natera, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- NeoGenomics Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PerkinElmer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Quest Diagnostics Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. US Women’s Health Diagnostics Market Research and Analysis by Application, 2025–2035 ($ Million)
2. US Breast Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
3. US Cervical Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
4. US Pregnancy & Fertility Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
5. US Ovarian Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
6. US Infectious Disease Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
7. US Ultrasound Tests Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
8. US Sexually Transmitted Disease Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
9. US Others Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
10. US Women’s Health Diagnostics Market Research and Analysis by End-Users, 2025–2035 ($ Million)
11. US Women’s Health Diagnostics for Diagnostic and Imaging Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
12. US Women’s Health Diagnostics for Hospitals and Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
13. US Women’s Health Diagnostics for Home Care Market Research and Analysis by Region, 2025–2035 ($ Million)
1. US Women’s Health Diagnostics Market Share by Application, 2025 Vs 2035 (%)
2. US Breast Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
3. US Cervical Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
4. US Pregnancy & Fertility Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
5. US Ovarian Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
6. US Infectious Disease Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
7. US Ultrasound Tests Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
8. US Sexually Transmitted Disease Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
9. US Others Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
10. US Women’s Health Diagnostics Market Share by End-Users, 2025 Vs 2035 (%)
11. US Women’s Health Diagnostics for Diagnostic and Imaging Centers Market Share by Region, 2025 Vs 2035 (%)
12. US Women’s Health Diagnostics for Hospitals and Clinics Market Share by Region, 2025 Vs 2035 (%)
13. US Women’s Health Diagnostics for Home Care Market Share by Region, 2025 Vs 2035 (%)
- Printable version
- No restriction to number of users within the company
